Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Zinner

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
R.I. Medical Journal|November 1, 1975
An antibiotic update: II. New aminoglycosides and other antibioticsP J Rubin, S H Zinner
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 2, 1999
In vitro dynamic model for determining the comparative pharmacology of fluoroquinolonesS H Zinner, A A Firsov
The New England Journal of Medicine|October 7, 1971
Long-term (10 to 14 years) follow-up of bacteriuria of pregnancyS H Zinner, E H Kass
The Journal of Infectious Diseases|October 1, 1981
Antistaphylococcal activity of rifampin with other antibioticsS H Zinner, H Lagast, J Klastersky
The American Journal of Medicine|June 30, 1986
In vitro models for the study of combination antibiotic therapy in neutropenic patientsS H Zinner, M Dudley, J Blaser
Antimicrobial Agents and Chemotherapy|August 1, 1981
Effect of mixing on rifampin bactericidal activity against staphylococciS H Zinner, M Husson, J Klastersky
Antimicrobial Agents and Chemotherapy|February 19, 2000
Comparative activities of ciprofloxacin and levofloxacin against Streptococcus pneumoniae in an In vitro dynamic modelS H Zinner, K Simmons, D Gilbert
Antimicrobial Agents and Chemotherapy|October 1, 1981
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureusH Lagast, S H Zinner, J Klastersky
The Journal of Infectious Diseases|December 1, 1981
An artificial capillary in vitro kinetic model of antibiotic bactericidal activityS H Zinner, M Husson, J Klastersky
The American Journal of Medicine|May 30, 1986
Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patientsS H Zinner, J Blaser, H Gaya
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
R.I. Medical Journal|November 1, 1975
An antibiotic update: II. New aminoglycosides and other antibioticsP J Rubin, S H Zinner
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 2, 1999
In vitro dynamic model for determining the comparative pharmacology of fluoroquinolonesS H Zinner, A A Firsov
The New England Journal of Medicine|October 7, 1971
Long-term (10 to 14 years) follow-up of bacteriuria of pregnancyS H Zinner, E H Kass
The Journal of Infectious Diseases|October 1, 1981
Antistaphylococcal activity of rifampin with other antibioticsS H Zinner, H Lagast, J Klastersky
The American Journal of Medicine|June 30, 1986
In vitro models for the study of combination antibiotic therapy in neutropenic patientsS H Zinner, M Dudley, J Blaser
Antimicrobial Agents and Chemotherapy|August 1, 1981
Effect of mixing on rifampin bactericidal activity against staphylococciS H Zinner, M Husson, J Klastersky
Antimicrobial Agents and Chemotherapy|February 19, 2000
Comparative activities of ciprofloxacin and levofloxacin against Streptococcus pneumoniae in an In vitro dynamic modelS H Zinner, K Simmons, D Gilbert
Antimicrobial Agents and Chemotherapy|October 1, 1981
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureusH Lagast, S H Zinner, J Klastersky
The Journal of Infectious Diseases|December 1, 1981
An artificial capillary in vitro kinetic model of antibiotic bactericidal activityS H Zinner, M Husson, J Klastersky
The American Journal of Medicine|May 30, 1986
Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patientsS H Zinner, J Blaser, H Gaya
Pageof 12